The Department of Medicine has forged an important community partnership with the AIDS Resource Center of Wisconsin (ARCW) Medical Center to provide medical care to more than 1,000 people living with HIV in Southeastern Wisconsin. This partnership brings high quality MCW medical care to low income and uninsured patients throughout the area.
The partnership is led by John Fangman, MD from the Division of Infectious Diseases who also serves as the Medical Director of the ARCW Medical Center, providing both clinic leadership and clinical care to patients. Christine Hogan, MD joins Dr. Fangman in providing care to ARCW’s patients. Drs. Fangman and Hogan provide care in partnership with three ARCW nurse practitioners and four registered nurses. The ARCW Medical Center is Wisconsin’s leading HIV Medical Home providing integrated medical, dental and mental health care and social support services including transportation assistance, legal representation, housing, financial assistance, drug treatment and food to help patients access care and achieve the best clinical outcomes. “The ARCW Medical Center is an innovate model of care that enables vulnerable patients to get outstanding medical, oral health and mental healthcare along with the supportive social services they need to successfully regain and maintain their health,” says Dr. Fangman. “I’m proud that MCW has committed so strongly to this partnership and am grateful for the opportunity to work at both these great institutions. It’s a model for HIV care that medical schools around the country should work to replicate.”
In addition to providing high quality clinical care for HIV patients, Dr. Fangman has worked closely with Dr. Mark Beilke and Dr. Mary Beth Graham from the Division of Infectious Diseases to develop education and research programs at ARCW. Medical students, resident and infectious disease fellows regularly rotate through the ARCW Medical Center. ARCW patients have been active participants in more than 10 MCW research protocols, with more on the horizon. These include industry-sponsored drug trials as well as a variety of investigator initiated projects including a Healthier Wisconsin Partnership Program-sponsored study of social network strategies to improve HIV diagnosis. Dr. Fangman is also working closely with Dr. Andy Petroll from the Division of Infectious Diseases and investigators from the MCW Department of Psychiatry’s Center for AIDS Intervention Research on studies designed to improve early diagnosis and effective long-term treatment of HIV.
Article written by John Fangman, MD, Infectious Diseases
Pulmonary Medicine and the PFT Lab
PFT's (Pulmonary Function Tests) are a group of tests that measure how the lungs take in and release air and how well they move gases such as oxygen from the atmosphere into the body's circulation. A PFT screening is ordered to determine the presence and/or progression of obstructive and restrictive diseases, shortness of breath, ventilator weaning, pre-operative evaluations and to measure a patient's exposure to contaminants that can affect lung function.
The primary instrument used in PFT testing is the spirometer. It is designed to measure changes in lung volume. A device is usually always attached to the spirometer which measures the movement of gas in and out of the chest and is referred to as a spirograph. At times the spirograph is replaced by a printer-like unit which provides a tracing called a spirogram. The unit has in memory all of the predicted values for gender, age groups, and race.
In an outpatient breathing test, a patient is asked to breathe into a small mouth piece attached to a machine that measures the lung capacity. This test determines how much air can go in and out of the lungs and whether the "air pipes" in the lungs are diseased. The PFT lab is located on the 2nd floor of the Pavilion.
In addition to the lab and Pulmonary clinic, members of the Pulmonary faculty are involved in research activities with the NIH in areas ranging from pulmonary edema to hypertension. One of the winners of the Women Pioneers in Research Awards, Dr. Elizabeth Jacobs, Professor and Division Chief, is the principal investigator of two National Heart, Lung and Blood Institute funded grants.
Marshall Dunning, III, PhD, Professor in the Division of Pulmonary Medicine, in collaboration with Anesthesiology, is studying the breakdown products of volatile inhalational anesthetics during their passage through desiccated carbon dioxide absorbents in anesthesia circuits, and the effect of CO2 from cigarette smoking prior to surgery on cardiac rhythm. He is also examining biomarkers of inflammation and oxidative stress found in exhaled breath condensate of individuals with COPD and asthma.
For additional information on the division's research or testing services, please call 414-805-3855.
Pulmonary Function Tests
Article written by Carla Clark, Staff Writer